Skip to main content
Clinical Trials/ISRCTN12437878
ISRCTN12437878
Completed
N/A

A multicentre randomised trial of the effectiveness of transcutaneous tibial nerve stimulation (TTNS) to reduce lower urinary tract symptoms in people with Parkinson’s

Glasgow Caledonian University0 sites208 target enrollmentJuly 22, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson’s disease with lower urinary tract symptoms
Sponsor
Glasgow Caledonian University
Enrollment
208
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2020 Protocol article in https://doi.org/10.1136/bmjopen-2019-034887 (added 23/08/2023)

Registry
who.int
Start Date
July 22, 2018
End Date
April 22, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnosis of Parkinson's disease with self\-reported problematic LUT symptoms
  • 2\. Capacity to consent/complete self\-report outcome measures
  • 3\. Ability to apply TTNS (or placebo) independently or has carer who can apply for duration
  • 4\. Stable Parkinson’s medication, treatment naïve, treatment failed or continuing treatment with anti\-muscarinic medication (group allocation will be minimised to account for these groups).

Exclusion Criteria

  • 1\. Pacemaker or implanted electrical device
  • 2\. Ulceration or broken skin in area of pad placement
  • 3\. History of gynaecological, urological cancer, prostate cancer
  • 4\. History of peripheral vascular disease, epilepsy or current urinary tract infection (as per dip stick analysis)
  • 5\. Pace\-maker, sacral nerve stimulator, receipt of Botox or PTNS within the last year
  • 6\. Severe prostatic enlargement as determined by treating clinician

Outcomes

Primary Outcomes

Not specified

Similar Trials